Alteration of protein glycosylation in liver diseasesBLOMME, Bram; VAN STEENKISTE, Christophe; CALLEWAERT, Nico et al.Journal of hepatology. 2009, Vol 50, Num 3, pp 592-603, issn 0168-8278, 12 p.Article

Hepatopulmonary syndrome and portopulmonary hypertension : what's new ?COLLE, Isabelle; VAN STEENKISTE, Christophe; GEERTS, Anja et al.Acta gastro-enterologica belgica (English ed.). 2007, Vol 70, Num 2, pp 203-209, issn 1784-3227, 7 p.Conference Paper

Proteomics in liver fibrosis is more than meets the eyeKIN JIP CHEUNG; TILLEMAN, Kelly; DEFORCE, Dieter et al.European journal of gastroenterology & hepatology. 2008, Vol 20, Num 5, pp 450-464, issn 0954-691X, 15 p.Article

Galectin-3-binding protein: a serological and histological assessment in accordance with hepatitis C-related liver fibrosisKIN JIP CHEUNG; LIBBRECHT, Louis; TILLEMAN, Kelly et al.European journal of gastroenterology & hepatology. 2010, Vol 22, Num 9, pp 1066-1073, issn 0954-691X, 8 p.Article

Diagnostic Value of the Hemopexin N-Glycan Profile in Hepatocellular Carcinoma PatientsDEBRUYNE, Evi N; VANDERSCHAEGHE, Dieter; VAN VLIERBERGHE, Hans et al.Clinical chemistry (Baltimore, Md.). 2010, Vol 56, Num 5, pp 823-831, issn 0009-9147, 9 p.Article

Serum levels of anti-NS4a and anti-NS5a predict treatment response of patients with chronic hepatitis CDESOMBERE, Isabelle; VAN VLIERBERGHE, Hans; WEILAND, Ola et al.Journal of medical virology. 2007, Vol 79, Num 6, pp 701-713, issn 0146-6615, 13 p.Article

Campylobacter-associated Guillain-Barré syndrome after orthotopic liver transplantation for hepatitis C cirrhosis: a case reportCOLLE, Isabelle; VAN VLIERBERGHE, Hans; TROISI, Roberto et al.Hepatology research. 2002, Vol 24, Num 2, pp 205-211, issn 1386-6346Article

Split liver transplantation with extended right grafts under patient-oriented allocation policy. Single center matched-pair outcome analysisSAINZ-BARRIGA, Mauricio; RICCIARDI, Salvatore; HAENTJENS, Ivo et al.Clinical transplantation. 2008, Vol 22, Num 4, pp 447-455, issn 0902-0063, 9 p.Article

Vascular hyporesponsiveness in the mesenteric artery of anaesthetized rats with cirrhosis and portal hypertension: an in-vivo studyCOLLE, Isabelle O; DE VRIESE, An S; VAN VLIERBERGHE, Hans R et al.European journal of gastroenterology & hepatology. 2004, Vol 16, Num 2, pp 139-145, issn 0954-691X, 7 p.Article

Cholestasis as presenting symptom of portal cavernomaCOLLE, Isabelle; VAN VLIERBERGHE, Hans; PATTYN, Piet et al.Hepatology research. 2003, Vol 25, Num 1, pp 32-37, issn 1386-6346, 6 p.Article

Effect of prolyl hydroxylase domain-2 haplodeficiency on the hepatocarcinogenesis in miceHEINDRYCKX, Femke; KUCHNIO, Anna; CASTELEYN, Christophe et al.Journal of hepatology. 2012, Vol 57, Num 1, pp 61-68, issn 0168-8278, 8 p.Article

Haptoglobin phenotype 2-2 overrepresentation in Cys282Tyr hemochromatotic patientsVAN VLIERBERGHE, Hans; LANGLOIS, Michel; DELANGHE, Joris et al.Journal of hepatology. 2001, Vol 35, Num 6, pp 707-711, issn 0168-8278Article

Efficacy of Interferon-Based Antiviral Therapy in Patients With Chronic Hepatitis C Infected With Genotype 5: A Meta-Analysis of Two Large Prospective Clinical TrialsD'HEYGERE, François; GEORGE, Christophe; VAN VLIERBERGHE, Hans et al.Journal of medical virology. 2011, Vol 83, Num 5, pp 815-819, issn 0146-6615, 5 p.Article

Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causesROBAEYS, Geert; VAN VLIERBERGHE, Hans; MATHEI, Catharina et al.European journal of gastroenterology & hepatology. 2006, Vol 18, Num 2, pp 159-166, issn 0954-691X, 8 p.Article

BASL guidelines for the surveillance, diagnosis and treatment of hepatocellular carcinomaVAN VLIERBERGHE, Hans; BORBATH, Ivan; DELWAIDE, Jean et al.Acta gastro-enterologica belgica (English ed.). 2004, Vol 67, Num 1, pp 14-25, issn 1784-3227, 12 p.Article

Radionuclide detection of peritoneovenous shunt patencyGEMMEL, Filip; RAVIER, Michel; TROISI, Roberto et al.Clinical nuclear medicine. 2003, Vol 28, Num 12, pp 986-987, issn 0363-9762, 2 p.Article

Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infectionLAI, Ching-Lung; ROSMAWATI, Mohamed; LAO, Judy et al.Gastroenterology (New York, NY. 1943). 2002, Vol 123, Num 6, pp 1831-1838, issn 0016-5085, 8 p.Article

Decreased leukocyte recruitment in the mesenteric microcirculation of rats with cirrhosis is partially restored by treatment with peginterferon : An in vivo studyGEERTS, Anja M; CHEUNG, Kin-Jip; VAN VLIERBERGHE, Hans et al.Journal of hepatology. 2007, Vol 46, Num 5, pp 804-815, issn 0168-8278, 12 p.Article

Oral fluid as a medium for the detection of hepatitis B surface antigenHUTSE, Veronik; VERHAEGEN, Els; VRANCKX, Robert et al.Journal of medical virology. 2005, Vol 77, Num 1, pp 53-56, issn 0146-6615, 4 p.Article

Modulation of portal graft inflow: A necessity in adult living-donor liver transplantation?TROISI, Roberto; CAMMU, Guy; VOET, Dirk et al.Annals of surgery. 2003, Vol 237, Num 3, pp 429-436, issn 0003-4932, 8 p.Article

A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis CNEVENS, Frederik; ROSKAMS, Tania; DINCQ, Stephanie et al.Hepatology (Baltimore, Md.). 2003, Vol 38, Num 5, pp 1289-1296, issn 0270-9139, 8 p.Article

Vascular corrosion casting: analyzing wall shear stress in the portal vein and vascular abnormalities in portal hypertensive and cirrhotic rodentsVAN STEENKISTE, Christophe; TRACHET, Bram; CASTELEYN, Christophe et al.Laboratory investigation. 2010, Vol 90, Num 11, pp 1558-1572, issn 0023-6837, 15 p.Article

The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine-induced mouse modelHEINDRYCKX, Femke; COULON, Stephanie; VAN VLIERBERGHE, Hans et al.Journal of hepatology. 2013, Vol 58, Num 2, pp 319-328, issn 0168-8278, 10 p.Article

Inhibition of Placental Growth Factor Activity Reduces the Severity of Fibrosis, Inflammation, and Portal Hypertension in Cirrhotic MiceVAN STEENKISTE, Christophe; RIBERA, Jordi; VAN GRUNSVEN, Leo A et al.Hepatology (Baltimore, Md.). 2011, Vol 53, Num 5, pp 1629-1640, issn 0270-9139, 12 p.Article

Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatmentORLENT, Hans; DESOMBERE, Isabelle; HANSEN, Bettina et al.European journal of gastroenterology & hepatology. 2010, Vol 22, Num 12, pp 1443-1448, issn 0954-691X, 6 p.Article